BridgeMD
New treatment option for Inguinal Hernia Repair
Official title Comparison of Outcomes of Hernia Sac Transection and Sac Reduction in Open Pediatric Inguinal Hernia Repair in Ramathibodi Hospital
ClinicalTrials.gov ID: NCT07252999
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if hernia sac transection works to treat pediatric inguinal hernia. Researchers will compare hernia sac transection to hernia sac reduction (traditional inguinal hernia repair) to see outcome in 6 months.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 to 18, men only
You may be able to join if
- Male pediatric patients under 18 years old
- Patients who underwent open inguinal hernia surgery on the affected side by a pediatric surgeon
- Patients who had follow-up after inguinal hernia surgery at Ramathibodi Hospital or phone follow-up (Telemed) for 6 months
- Patients who agree to participate in the study by signing an informed consent form
You likely can't join if
- Preterm infants
- Inguinal hernia patients with strangulated hernia
- Patients with non-communicating hydrocele
- Patients who had follow-up at another hospital after inguinal hernia surgery
- Patients who refused to participate in the study or withdrawn
The study team makes the final eligibility decision.
Where it's taking place
- Ratchathewi, Bangkok, Thailand
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 1 day to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ratchathewi, Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.